SANGAMO THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 366000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2010-12-31) |
| Status | current |
| Entity | SANGAMO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T09:41:46.934068+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/47208038-cf5a-402b-8b5b-f4f42fbd9a9c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-11-212305Retrieved: 2026-08-19T09:41:46.934068+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001001233/accounts-receivable/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/47208038-cf5a-402b-8b5b-f4f42fbd9a9c
History
- no predecessors — first report